[HTML][HTML] Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale
H Magnussen, H Watz, A Kirsten, M Decramer… - Respiratory …, 2014 - Elsevier
Long-acting bronchodilators in combination with inhaled corticosteroids (ICS) are
recommended to decrease the risk of recurrent exacerbations in patients with Global …
recommended to decrease the risk of recurrent exacerbations in patients with Global …
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD …
A Rossi, M Guerriero, A Corrado - Respiratory research, 2014 - Springer
Background It has been suggested that withdrawal of inhaled corticosteroids (ICS) in COPD
patients on maintenance treatment results in deterioration of symptoms, lung function and …
patients on maintenance treatment results in deterioration of symptoms, lung function and …
Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings
P Rogliani, BL Ritondo, M Gabriele… - Expert Review of …, 2020 - Taylor & Francis
Introduction To date, there is solid evidence from randomized controlled trials (RCTs)
supporting the rationale for withdrawal from inhaled corticosteroids (ICSs) in most patients …
supporting the rationale for withdrawal from inhaled corticosteroids (ICSs) in most patients …
Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice
AG Kaplan - … Journal of Chronic Obstructive Pulmonary Disease, 2015 - Taylor & Francis
Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …
Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?
Clinical trials in chronic obstructive pulmonary disease (COPD) patients have shown that the
long-term use of inhaled corticosteroids (ICS) in COPD patients reduced the number of …
long-term use of inhaled corticosteroids (ICS) in COPD patients reduced the number of …
[HTML][HTML] Withdrawal of inhaled glucocorticoids and exacerbations of COPD
H Magnussen, B Disse… - … England Journal of …, 2014 - Mass Medical Soc
Background Treatment with inhaled glucocorticoids in combination with long-acting
bronchodilators is recommended in patients with frequent exacerbations of severe chronic …
bronchodilators is recommended in patients with frequent exacerbations of severe chronic …
Weaning from inhaled corticosteroids in COPD: the evidence
The use of inhaled corticosteroids (ICS) in the treatment of chronic obstructive pulmonary
disease (COPD) has been widely debated [1–3]. Treatment guidelines have suggested that …
disease (COPD) has been widely debated [1–3]. Treatment guidelines have suggested that …
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world'study
CF Vogelmeier, H Worth, R Buhl, CP Criée… - Respiratory …, 2022 - Springer
Introduction Chronic obstructive pulmonary disease (COPD) guidelines recommend
reserving triple therapy of inhaled corticosteroid (ICS), long-acting β2-agonist (LABA) and …
reserving triple therapy of inhaled corticosteroid (ICS), long-acting β2-agonist (LABA) and …
The effect on total mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: a real practice analysis in Italy
M Di Martino, N Agabiti, S Cascini… - COPD: Journal of …, 2016 - Taylor & Francis
Purpose. Chronic therapy with long-acting bronchodilators (LB) is recommended to treat
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis
Background: Several clinical trials have evaluated the benefits associated with adding an
inhaled corticosteroid (ICS) to a long-acting bronchodilator in the treatment of severe or very …
inhaled corticosteroid (ICS) to a long-acting bronchodilator in the treatment of severe or very …
相关搜索
- copd patients inhaled corticosteroids
- dual bronchodilation stepwise withdrawal
- inhaled corticosteroids stepwise withdrawal
- dual bronchodilation inhaled corticosteroids
- copd patients stepwise withdrawal
- copd patients dual bronchodilation
- copd patients low risk
- inhaled glucocorticoids exacerbations of copd
- inhaled corticosteroids low risk
- inhaled corticosteroids appropriateness of treatment
- inhaled corticosteroids unfinished history
- copd patients appropriateness of treatment
- inhaled corticosteroids clinical practice
- patients with copd clinical practice
- inhaled corticosteroids proposed algorithm
- inhaled corticosteroids total mortality